JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pirinen, R T
Right arrow Articles by Kosma, V-M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pirinen, R T
Right arrow Articles by Kosma, V-M
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Lung Cancer
J Clin Pathol 2001; 54:391-395
© 2001 Journal of Clinical Pathology

Reduced expression of {alpha}-catenin, ß-catenin, and {gamma}-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer

R T Pirinen1, P Hirvikoski2, R T Johansson3, S Hollmén4, V-M Kosma1

1 Departments of Pathology and Forensic Medicine, University of Kuopio and Kuopio University Hospital, PO Box 1627, FIN-70211 Kuopio, Finland
2 Department of Pathology, Centre for Laboratory Medicine, Tampere University Hospital, PO Box 2000, FIN-33521 Tampere, Finland
3 Department of Oncology, University of Kuopio and Kuopio University Hospital
4 Department of Pathology, Satakunta Central Hospital, FIN-28500 Pori, Finland

Dr Kosma Velimatti.Kosma{at}uku.fi Aims—To investigate the expression of catenins ({alpha}, ß, and {gamma}) in non-small cell lung carcinoma (NSCLC) and its relation to clinicopathological factors and prognosis.

Methods—The expression of catenins was analysed immunohistochemically in 261 patients with resected NSCLC, diagnosed between 1978 and 1996 in eastern Finland. The cell proliferation index of the tumours was analysed by means of an image analyser. The staining results were compared with clinicopathological characteristics and survival.

Results—Normal catenin staining was found significantly more often in adenocarcinomas than in squamous cell carcinomas or anaplastic/large cell carcinomas. Reduced staining of {alpha}-catenin, ß-catenin, and {gamma}-catenin was related to poor differentiation of the tumour. The tumours with reduced staining of ß-catenin or {gamma}-catenin often had higher cell proliferation activity. Nuclear staining of ß-catenin and {gamma}-catenin was found in 16 (7%) and 29 (13%) cases, respectively. This nuclear staining correlated directly with increased cell proliferation and inversely with membranous staining. In survival analyses the predictors of overall and disease free survival were stage and tumour type. The expression of catenins did not affect survival.

Conclusions—The expression of {alpha}-catenin, ß-catenin, and {gamma}-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value. However, this study supports the important role of the nuclear accumulation of ß-catenin and {gamma}-catenin in highly proliferative cells.

Key Words: catenin • lung cancer • proliferation • differentiation




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
T Leinonen, R Pirinen, J Bohm, R Johansson, A Rinne, E Weber, and V-M Kosma
Biological and prognostic role of acid cysteine proteinase inhibitor (ACPI, cystatin A) in non-small-cell lung cancer
J. Clin. Pathol., May 1, 2007; 60(5): 515 - 519.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Shen, C. Behrens, I. I. Wistuba, L. Feng, J. J. Lee, W. K. Hong, and R. Lotan
Identification and Validation of Differences in Protein Levels in Normal, Premalignant, and Malignant Lung Cells and Tissues Using High-Throughput Western Array and Immunohistochemistry
Cancer Res., December 1, 2006; 66(23): 11194 - 11206.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Gastaldi, P. Bonvini, F. Sartori, A. Marrone, A. Iolascon, and A. Rosolen
Plakoglobin is differentially expressed in alveolar and embryonal rhabdomyosarcoma and is regulated by DNA methylation and histone acetylation
Carcinogenesis, September 1, 2006; 27(9): 1758 - 1767.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
C-Q Zhu, W Shih, C-H Ling, and M-S Tsao
Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation.
J. Clin. Pathol., August 1, 2006; 59(8): 790 - 800.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C.-l. Huang, D. Liu, J. Nakano, S. Ishikawa, K. Kontani, H. Yokomise, and M. Ueno
Wnt5a Expression Is Associated With the Tumor Proliferation and the Stromal Vascular Endothelial Growth Factor--An Expression in Non-Small-Cell Lung Cancer
J. Clin. Oncol., December 1, 2005; 23(34): 8765 - 8773.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
A Ramburan, F Oladiran, C Smith, G P Hadley, and D Govender
Microsatellite analysis of the adenomatous polyposis coli (APC) gene and immunoexpression of {beta} catenin in nephroblastoma: a study including 83 cases treated with preoperative chemotherapy
J. Clin. Pathol., January 1, 2005; 58(1): 44 - 50.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. A. Winn and L. E. Heasley
{gamma}-Catenin Expression Is Reduced or Absent in a Subset of Human Non-small Cell Lung Cancers, and Its Re-expression Inhibits Cell Growth
Chest, May 1, 2004; 125(5_suppl): 122S - 123S.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
Y. S. Choi, Y. M. Shim, S.-H. Kim, D. S. Son, H.-S. Lee, G. Y. Kim, J. Han, and J. Kim
Prognostic significance of E-cadherin and {beta}-catenin in resected stage I non-small cell lung cancer
Eur. J. Cardiothorac. Surg., September 1, 2003; 24(3): 441 - 449.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Kotsinas, K. Evangelou, P. Zacharatos, C. Kittas, and V. G. Gorgoulis
Proliferation, but Not Apoptosis, Is Associated with Distinct {beta}-Catenin Expression Patterns in Non-Small-Cell Lung Carcinomas : Relationship with Adenomatous Polyposis Coli and G1-to S-Phase Cell-Cycle Regulators
Am. J. Pathol., November 1, 2002; 161(5): 1619 - 1634.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Shtutman, J. Zhurinsky, M. Oren, E. Levina, and A. Ben-Ze'ev
PML Is a Target Gene of {beta}-Catenin and Plakoglobin, and Coactivates {beta}-Catenin-mediated Transcription
Cancer Res., October 15, 2002; 62(20): 5947 - 5954.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
M. Kofron, J. Heasman, S. A. Lang, and C. C. Wylie
Plakoglobin is required for maintenance of the cortical actin skeleton in early Xenopus embryos and for cdc42-mediated wound healing
J. Cell Biol., August 19, 2002; 158(4): 695 - 708.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. M. Bremnes, R. Veve, E. Gabrielson, F. R. Hirsch, A. Baron, L. Bemis, R. M. Gemmill, H. A. Drabkin, and W. A. Franklin
High-Throughput Tissue Microarray Analysis Used to Evaluate Biology and Prognostic Significance of the E-Cadherin Pathway in Non-Small-Cell Lung Cancer
J. Clin. Oncol., May 15, 2002; 20(10): 2417 - 2428.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2001 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.